Trupanion, Inc. filings document the company’s pet medical insurance business, public-company governance, and capital structure. Form 8-K reports include quarterly and annual operating results, with disclosures on subscription revenue, enrolled pets, net acquisition cost, adjusted EBITDA, operating cash flow, and other measures used to describe the company’s insurance economics.
The filing record also covers material agreements, including credit facilities, secured borrowings, maturity terms, covenants, and limits on corporate actions. Proxy materials document director elections, board composition, executive compensation, equity awards, shareholder voting matters, and related governance disclosures.
TRUPANION, INC. Chief Administration Officer Brenna McGibney reported equity compensation activity, including a new award and vesting of existing restricted stock units. On February 20, 2026, she received a grant of 21,212 restricted stock units (RSUs) that will vest in eighths starting May 22, 2026, then quarterly.
On February 22, 2026, multiple RSU tranches vested and converted into common stock on a one-for-one basis, increasing her direct common stock holdings through derivative exercises. On the same date, 699, 724, and 1,007 common shares were withheld at $27.16 per share to satisfy tax obligations, which the disclosure states does not represent a sale by the reporting person. After these transactions, she directly held 8,150 shares of common stock.
TRUPANION, INC. executive Steve Weinrauch, EVP North America & Vet Strategy, reported multiple equity compensation moves. On February 20, 2026, he was granted 12,260 restricted stock units (RSUs), which convert into common stock on a one-for-one basis and vest in eighths starting May 22, 2026, then quarterly, subject to continued service.
On February 22, 2026, previously granted RSUs were exercised and converted into 2,932 and 2,029 shares of common stock. To cover income tax withholding related to these vestings, 869 and 601 shares of common stock were withheld by the company at $27.16 per share, which the filing notes does not represent a sale by Weinrauch. After these transactions, he directly held 71,857 shares of common stock and 12,260 RSUs.
Trupanion, Inc. Chief Financial Officer Fawwad Qureshi reported multiple equity compensation transactions involving restricted stock units (RSUs) and common stock. On February 20, 2026, he was granted 35,482 RSUs that vest as to 1/8 of the total on May 22, 2026, then 1/8 quarterly, subject to continued service.
On February 22, 2026, several RSU awards vested and converted into common stock on a one-for-one basis, resulting in acquisitions of common shares at a price of $0.00 per share through derivative exercises. The filing also shows dispositions of 270, 1,467, and 92 common shares at $27.16 per share to satisfy tax withholding obligations in connection with those vestings, which the footnotes state do not represent sales by Qureshi in the open market.
TRUPANION, INC. Chief Legal Officer Asher Bearman reported equity compensation activity and related tax withholding. On February 20, 2026, he was granted 14,656 restricted stock units (RSUs) that vest in eighths beginning May 22, 2026, then quarterly, subject to continued service. On February 22, 2026, previously granted RSUs vested, converting a total of 1,627 RSUs into common stock on a one-for-one basis. To cover income tax obligations, the issuer withheld 609 shares of common stock at $27.16 per share; footnotes state this is not a sale by the reporting person. After these transactions, Bearman directly held 70,290 shares of Trupanion common stock.
Trupanion, Inc. Chief Revenue Officer Emily Dreyer reported equity compensation activity and related tax share withholding. On February 20, 2026, she was granted 10,282 restricted stock units (RSUs), which vest as to 1/8 of the total on May 22, 2026 and then 1/8 quarterly, subject to continued service.
On February 22, 2026, previously granted RSUs converted into 2,249 and 1,340 shares of common stock, and Dreyer acquired the same number of common shares at a price of $0.00 per share. In connection with these vestings, 666 and 397 shares of common stock were withheld at $27.16 per share to cover tax obligations, which the footnotes state does not represent a sale by the reporting person. After these transactions, Dreyer directly owned 42,037 shares of common stock and held 10,282 RSUs.
Trupanion director Bradley S. Powell reported an equity award vesting and share conversion. On February 22, 2026, 638 restricted stock units (RSUs) vested and were exercised or converted into 638 shares of Trupanion common stock at a stated price of $0.00 per share.
These RSUs come from a grant of 1,906 units awarded on November 14, 2025. According to the grant terms, the award vests and converts into common stock in three equal portions on November 22, 2025, February 22, 2026, and May 22, 2026, subject to Powell’s continued service through each vesting date.
TRUPANION, INC. executive Simon Wheeler, EVP of Trupanion International, reported multiple equity compensation events. On February 20, 2026, he received a grant of 3,079 restricted stock units (RSUs), which vest over time, starting with 1/8 of the total on May 22, 2026 and then quarterly, subject to continued service.
On February 22, 2026, several previously granted RSUs vested and converted on a one-for-one basis into common stock, shown as exercises or conversions of derivative securities. On the same date, a portion of the newly issued shares (440, 717 and 247 shares at a reference price of $27.16) was withheld to cover income tax obligations, which the company states does not represent a sale by Wheeler. After these transactions, Wheeler holds directly owned common stock and remaining RSU balances reflecting ongoing vesting schedules from grants made in 2024, 2025 and 2026.
Trupanion director Howard E. Rubin reported acquiring common shares through restricted stock unit (RSU) vesting. On February 22, 2026, 318 RSUs converted on a one-for-one basis into 318 shares of Trupanion common stock at $0.00 per share via derivative exercises coded “M.”
These RSUs stem from three grants of 423 units each received on May 9, 2025 for service on boards of wholly owned subsidiaries, vesting in four equal quarterly installments. Following these conversions, Rubin directly owned 232,550 shares of Trupanion common stock.
TRUPANION, INC. CEO and director Margaret Tooth reported a series of equity compensation transactions. On February 20, 2026, she was granted 65,497 restricted stock units (RSUs) at $0.00 per unit, which will vest in installments beginning May 22, 2026, subject to continued service.
On February 22, 2026, multiple RSU tranches were exercised and converted into common stock, and corresponding common stock entries show acquisitions at $0.00 per share reflecting those conversions. Separate entries report dispositions of common stock at $27.16 per share to satisfy income tax withholding obligations, and the footnotes clarify these withholdings do not represent sales by Tooth.
TRUPANION director Darryl Rawlings increased his direct ownership through RSU conversions. On February 22, 2026, restricted stock units converted into common stock on a one-for-one basis, resulting in the acquisition of 6,563 common shares at a price of $0.0000 per share.
Following these transactions, Rawlings directly owned 41,286 shares of common stock. The RSU grants were originally awarded on February 27, 2024, with scheduled vesting over time, subject to continued service through each vesting date.